SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

MLA

Ceriani, Luca, et al. “SAKK38/07 Study: Integration of Baseline Metabolic Heterogeneity and Metabolic Tumor Volume in DLBCL Prognostic Model.” Blood Advances, vol. 4, no. 6, Mar. 2020, pp. 1082–92. EBSCOhost, https://doi.org/10.1182/bloodadvances.2019001201.

APA

Ceriani, L., Gritti, G., Cascione, L., Pirosa, M. C., Polino, A., Ruberto, T., Stathis, A., Bruno, A., Moccia, A. A., Giovanella, L., Hayoz, S., Schär, S., Dirnhofer, S., Rambaldi, A., Martinelli, G., Mamot, C., & Zucca, E. (2020). SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model. Blood Advances, 4(6), 1082–1092. https://doi.org/10.1182/bloodadvances.2019001201

Chicago

Ceriani, Luca, Giuseppe Gritti, Luciano Cascione, Maria Cristina Pirosa, Angela Polino, Teresa Ruberto, Anastasios Stathis, et al. 2020. “SAKK38/07 Study: Integration of Baseline Metabolic Heterogeneity and Metabolic Tumor Volume in DLBCL Prognostic Model.” Blood Advances 4 (6): 1082–92. doi:10.1182/bloodadvances.2019001201.